Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Copovidone (PVP-VA) Market Expansion From $1.18 Billion In 2026 To $1.67 Billion In 2030
The copovidone (PVP-VA) market size has witnessed substantial growth in recent years. It is forecast to expand from $1.08 billion in 2025 to $1.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.3%. The expansion observed in the past can be attributed to the rising demand for oral solid dosage drugs and generics, the increasing requirement for solubility enhancers for active ingredients with poor water solubility, the ongoing development of advanced drug-delivery systems that necessitate high-performance binders, and the growing incorporation of copovidone in film-coated and controlled-release formulations.
The copovidone (PVP-VA) market is projected to experience robust expansion over the coming years, reaching a valuation of $1.67 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.1%. This anticipated growth during the forecast period is primarily due to several factors: the escalating adoption of versatile polymers in cosmetics and personal-care formulations, a rising demand for multifunctional excipients across food, nutraceutical, and industrial sectors, enhanced regulatory approval and quality benchmarks supporting copovidone, and increased financial commitments toward innovative formulations that utilize copovidone. Key trends identified for this period encompass progress in employing copovidone for poorly water-soluble drugs through hot-melt extrusion and spray-drying, novel developments in controlled-release and solvent-free drug formulations, the incorporation of copovidone into nutraceutical and cosmeceutical offerings, improvements in regulatory harmonization to streamline global distribution, and advancements in multifunctional excipient blends where copovidone is combined with other polymers.
Download A Free Sample Report For Comprehensive Market Insights:
Copovidone (PVP-VA) Market Demand Drivers: What Is Fueling Industry Growth?
The copovidone (PVP-VA) market is expected to experience growth driven by the increasing need for biopharmaceuticals. Biopharmaceuticals are therapeutic products derived from biological sources or biotechnology processes, as opposed to conventional chemical synthesis. The heightened demand for these products is a result of the rising occurrence of chronic and complex diseases, which creates a need for sophisticated, targeted therapies that traditional drugs are often unable to address effectively. Copovidone (PVP-VA) supports the demand for biopharmaceuticals by offering versatile formulation and stabilizing attributes, making it an excellent choice for advanced drug delivery systems. It enhances drug solubility, stability, and bioavailability, thereby improving overall therapeutic effectiveness and fostering the development of innovative biopharmaceutical products. For instance, in June 2025, the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, reported that prescription drug outlays increased by 11.4% in 2023 to $449.7 billion, showing an acceleration from the 7.8% growth recorded in 2022. Therefore, the expanding demand for biopharmaceuticals is a primary driver for the growth of the copovidone (PVP-VA) market.
Copovidone (PVP-VA) Market Segments: Where Are The Largest Growth Opportunities?
The copovidone (pvp-va) market covered in this report is segmented –
1) By Type: Copovidone, PVP-VA 64, PVP-VA 73
2) By Product Form: Powder, Liquid
3) By Application: Pharmaceuticals, Cosmetics, Food And Beverage, Adhesives, Coatings
4) By Distribution Channel: Direct Sales, Distributors, Online Retailers
Subsegments:
1) By Copovidone: Direct Compression Grade, Wet Granulation Grade, Film-Forming Grade, Sustained-Release Applications, Immediate-Release Applications
2) By PVP-VA 64: Tablet Binding Applications, Film-Coating Applications, Granulation Applications, Solubility-Enhancement Uses, Hot-Melt Extrusion Applications
3) By PVP-VA 73: High-Viscosity Formulations, Controlled-Release Systems, Solid Dispersion Formulations, Capsule Filling Applications, Stabilization Of Active Ingredients
Copovidone (PVP-VA) Market Innovation Trends: Which Developments Are Transforming The Industry?
Major companies within the copovidone (PVP-VA) market are focusing on developing advanced product grades and services, such as nitrite-tested grades, to boost regulatory compliance, enhance drug safety, and reduce nitrosamine risk. Nitrite-tested grades specifically refer to enhanced quality assurance services for excipients, where each delivered batch is tested for nitrites, a potential precursor to nitrosamines, with results documented on the Certificate of Analysis. For instance, in August 2025, BASF SE, a Germany-based chemical and materials company, launched Kollidon Nitrite Tested (NT) grades. This represents an advanced service tier designed to support customers’ nitrosamine control strategies through improved nitrite testing and documentation for key products, including Kollidon VA 64 NT. The service includes nitrite tests on the respective product specification, with results reported on the Certificate of Analysis (CoA) for all delivered batches, providing an additional layer of quality assurance and documentation.
Copovidone (PVP-VA) Market Major Participants And Competitive Dynamics
Major companies operating in the copovidone (pvp-va) market are BASF SE, Ashland Global Holdings Inc., Hangzhou Motto Science & Technology Co. Ltd., JRS Pharma GmbH & Co. KG, Boai NKY Pharmaceuticals Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Luxi Group Co. Ltd., Zhongbao Chemicals Co. Ltd., Autech Industry Co. Ltd., Huangshan Bonsun Pharmaceuticals Co. Ltd., Ningbo Inno Pharmchem Co. Ltd., Shanghai Yuking Water Soluble Material Technology Co. Ltd., Tianjin YR Chemspec Technology Co. Ltd., Star-Tech Specialty Products Co. Ltd., JH Nanhang Life Sciences Co. Ltd., Huzhou Sunflower Specialty Polymer Co. Ltd., Jiaozuo Zhongwei Special Products Pharmaceutical Co. Ltd., Ulanqab Kema New Material Co. Ltd., Sunfair PCS Polymer Material (Nanjing) Co. Ltd., Hefei Trendchem Co. Ltd.
Access The Complete Copovidone (PVP-VA) Market Report:
#Copovidone (PVP-VA) Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the copovidone (PVP-VA) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the copovidone (pvp-va) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.